Hedge Fund Database

PERCEPTIVE ADVISORS

PERCEPTIVE ADVISORS LLC. Legal Name

Adviser information for PERCEPTIVE ADVISORS last updated from Form ADV on March 28th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.

Advisory Business

Type of Organization Limited Liability Company
Fiscal Year End DECEMBER
Legal Location Delaware, United States

Employees

Total Number of Employees 46
Investment Advisory/Research 30
Registered Broker-Dealer Representatives 0
Registered State Investment Advisers 0
Licensed Agents of an Insurance Company 0
No. of Firms/People that Solicit Clients 0

RAUM

Provides Management of Securities Portfolios Yes
Type Accounts RAUM
Discretionary 29 $9.7B
Non-Discretionary 0 $0
Total 29 $9.7B

Clients

Type Number RAUM
Individuals 0 $0
HNW Individuals 0 $0
Banking or thrift institutions 0 $0
Investment companies 0 $0
Business development companies 0 $0
Pooled investment vehicles 28 $9.6B
Pension and profit sharing plans 0 $0
Charitable organizations 0 $0
State or municipal gov entities 0 $0
Other investment advisers 0 $0
Insurance companies 0 $0
Sovereign wealth funds and foreign official institutions 0 $0
Corporations or other businesses 0 $0
Other <5 $140.1M
Type Number
No. of Non-RAUM Clients 0
No. of Non-U.S. Clients 24

Services

Advisory Services Portfolio management for pooled investment vehiclesPORTFOLIO MANAGEMENT OF PROPRIETARY CAPITAL
Compensation % of AUMPerformance-based fees
Other Business Activities Commodity pool operator or commodity trading advisor

Identifiers

SEC RIA File Number 801-71841
SEC ERA File Number 801-71841
SEC CIK Numbers 1224962
SEC CRD Numbers 154703
Legal Entity Identifier 54930051M1DQYADROP30

Principal Office

51 ASTOR PLACE
10TH FLR
NEW YORK
NY
United States
Monday - Friday, 7 AM - 6PM
Tel: 646-205-5300, Fax: 646-205-5301

Websites

www.linkedin.com/company/perceptive-advisors-llc/ www.perceptivelife.com

Chief Compliance Officer

ALEXANDER RAKITIN
51 ASTOR PLACE
10TH FLR
NEW YORK
NY
United States
Tel: 646-205-5300
Fax: 646-205-5301
(Full email address available in API data)

Regulatory Contact

JAMES MANNIX
COO
51 ASTOR PLACE
10TH FLR
NEW YORK
NY
United States
Tel: 646-205-5300
(Full email address available in API data)

Industry Affiliates

ARYA SCIENCES ACQUISITION CORP IV Sponsor or syndicator of limited partnerships
ARYA SCIENCES ACQUISITION CORP VI Sponsor or syndicator of limited partnerships
LEV LB HOLDINGS GP, LLC Sponsor, GP, manager of pooled investment vehicles
PCOF EQ AIV GP, LLC Sponsor, GP, manager of pooled investment vehicles
PERCEPTIVE CAPITAL, LLC Sponsor, GP, manager of pooled investment vehicles
PERCEPTIVE CREDIT OPPORTUNITIES GP, LLC Sponsor, GP, manager of pooled investment vehicles
PERCEPTIVE DISCOVERY GP LLC Sponsor, GP, manager of pooled investment vehicles
PERCEPTIVE LS GP, LLC Sponsor, GP, manager of pooled investment vehicles
PERCEPTIVE SP GP, LLC Sponsor, GP, manager of pooled investment vehicles
PERCEPTIVE XONTOGENY VENTURE GP, LLC Sponsor, GP, manager of pooled investment vehicles

Private Funds

Name Type Assets $USD Min Investment $USD No. Owners
LEV LB HOLDINGS, LP Private Equity Fund $97.8M $0.0M 37
PCOF EQ AIV II, LP CREDIT-RELATED FUND $4.0M $0.0M 48
PCOF EQ AIV III, LP CREDIT-RELATED FUND $7.0M $0.0M 101
PCOF EQ AIV IV, LP CREDIT-RELATED FUND $0.0M $0.0M 118
PCOF PHOENIX II AIV III, LP CREDIT-RELATED FUND $0.0M $0.0M 1
PCOF PHOENIX II FUND, LP Hedge Fund $207.3M $5.0M 4
PERCEPTIVE CREDIT OPPORTUNITIES FUND IV, LP Hedge Fund $1,367.5M $5.0M 285
PERCEPTIVE CREDIT OPPORTUNITIES FUND II, LP Hedge Fund $540.4M $5.0M 123
PERCEPTIVE CREDIT OPPORTUNITIES FUND III, LP Hedge Fund $1,074.6M $5.0M 151
PERCEPTIVE DISCOVERY FUND A LP Private Equity Fund $0.0M $1.0M 0
PERCEPTIVE DISCOVERY FUND LP Private Equity Fund $0.0M $1.0M 0
PERCEPTIVE LIFE SCIENCES MASTER FUND, LTD Hedge Fund $5,573.8M $1.0M 400
PERCEPTIVE LS (A), LLC Private Equity Fund $6.8M $0.0M 5
PERCEPTIVE SP (C), LP Private Equity Fund $3.9M $0.0M 5
PERCEPTIVE SP (E), LP Private Equity Fund $0.0M $0.0M 1
PERCEPTIVE XONTOGENY VENTURE FUND II, LP Venture Capital Fund $507.9M $0.5M 181
PERCEPTIVE XONTOGENY VENTURE FUND, LP Venture Capital Fund $179.1M $0.5M 134
PX VENTURE (A), LLC Private Equity Fund $2.1M $0.0M 5
PX VENTURE (B), LLC Private Equity Fund $0.4M $0.0M 15
PX VENTURE (C), LLC Private Equity Fund $3.9M $0.0M 1

Control Persons

Name Type Entity Title Since Ownership
EDELMAN, JOSEPH, ERIC Individual – CHIEF EXECUTIVE OFFICER AND PORTFOLIO MANAGER 12/2000 > 75%
MANNIX, JAMES, HENRY Individual – CHIEF OPERATING OFFICER 12/2006 < 5%
FIERRO, PETER, WILLIAM Individual – CHIEF FINANCIAL OFFICER 07/2007 < 5%
RAKITIN, ALEXANDER, NMN Individual – CHIEF COMPLIANCE OFFICER 10/2017 < 5%

No. Employees, Historic

50250201920202021202220232024202527 on 4/10/201926 on 3/30/202029 on 3/30/202129 on 5/20/202138 on 3/31/202238 on 9/13/202239 on 3/30/202346 on 3/20/202446 on 3/28/2024

RAUM, Historic

20B10B020192020202120222023202420255041667000 on 4/10/20198121997497 on 3/30/202013490322000 on 3/30/202113490322000 on 5/20/202110357828753 on 3/31/202210357828753 on 9/13/20229508525129 on 3/30/20239855817417 on 3/20/20249715749804 on 3/28/2024

No. Clients, Historic

40200201920202021202220232024202513 on 4/10/201922 on 3/30/202027 on 3/30/202127 on 5/20/202132 on 3/31/202232 on 9/13/202230 on 3/30/202328 on 3/20/202429 on 3/28/2024

Holdings

From latest 13F, filed August 16th, 2024 for period ending June 30th, 2024
Name Class Value $USD # Shares Private Fund
ABSCI CORPORATION COM 2M 700K –
ACRIVON THERAPEUTICS INC COMMON STOCK 31M 5M –
ADMA BIOLOGICS INC COM 31M 3M –
AKERO THERAPEUTICS INC COM 35M 1M –
ALDEYRA THERAPEUTICS INC COM 31M 9M –
ALLOGENE THERAPEUTICS INC COM 6M 3M –
AMICUS THERAPEUTICS INC COM 278M 28M –
APOGEE THERAPEUTICS INC COM 83M 2M –
APPLIED THERAPEUTICS INC COM 37M 8M –
ARCELLX INC COMMON STOCK 215M 4M –
ARCUTIS BIOTHERAPEUTICS INC COM 14M 2M –
ARGENX SE SPONSORED ADR 7M 16K –
ARRIVENT BIOPHARMA INC COM 8M 415K –
ARS PHARMACEUTICALS INC COM 7M 867K –
ARTIVION INC COM 72M 3M –
ARVINAS INC COM 27M 1M –
ASTRIA THERAPEUTICS INC COM 59M 6M –
ATHIRA PHARMA INC COM 14M 5M –
AXOGEN INC COM 220K 30K –
AXSOME THERAPEUTICS INC COM 37M 459K –
BICYCLE THERAPEUTICS PLC SPONSORED ADS 12M 572K –
BIOHAVEN LTD COM 52M 1M –
BIODESIX INC COM 3M 2M –
BRIDGEBIO PHARMA INC COM 31M 1M –
CABALETTA BIO INC COM 4M 585K –
CAREMAX INC CL A NEW 342K 123K –
CAREMAX INC *W EXP 06/08/202 846 60K –
CARGO THERAPEUTICS INC COM 60M 4M –
CASSAVA SCIENCES INC COM 2M 183K –
CELCUITY INC COM 39M 2M –
CENTESSA PHARMACEUTICALS PLC SPONSORED ADS 36M 4M –
CEREVEL THERAPEUTICS HLDNG I COM 441M 11M –
CG ONCOLOGY INC COM 23M 734K –
CONTINEUM THERAPEUTICS INC CL A 28M 2M –
CRINETICS PHARMACEUTICALS IN COM 66M 1M –
CULLINAN THERAPEUTICS INC COM 13M 750K –
DISC MEDICINE INC COM 25M 553K –
EAGLE PHARMACEUTICALS INC COM 971K 173K –
EDGEWISE THERAPEUTICS INC COM 33M 2M –
ENGENE HOLDINGS INC COM 8M 800K –
ENVVENO MEDICAL CORPORATION COM 3M 623K –
EVOLUS INC COM 62M 6M –
EYEPOINT PHARMACEUTICALS INC COM NEW 6M 640K –
FATE THERAPEUTICS INC COM 1M 346K –
FOGHORN THERAPEUTICS INC COM 3M 544K –
FORTE BIOSCIENCES INC COM 2M 3M –
HELIX ACQUISITION CORP II CL A ORD SHS 5M 500K –
ICON PLC SHS 10M 31K –
IMMATICS N.V SHS 94M 8M –
IMMUNOVANT INC COM 51M 2M –
IMMUNOVANT INC COM 5M 200K –
INHIBRX BIOSCIENCES INC COM 15M 1M –
INSMED INC COM PAR $.01 12M 180K –
INTRA-CELLULAR THERAPIES INC COM 118M 2M –
INTUITIVE SURGICAL INC COM NEW 27M 62K –
IOVANCE BIOTHERAPEUTICS INC COM 208M 26M –
IRHYTHM TECHNOLOGIES INC COM 4M 35K –
KALVISTA PHARMACEUTICALS INC COM 6M 500K –
KYVERNA THERAPEUTICS INC COM 1M 150K –
LIVANOVA PLC SHS 24M 444K –
LYRA THERAPEUTICS INC COM 4M 13M –
MADRIGAL PHARMACEUTICALS INC COM 74M 265K –
MEDTRONIC PLC SHS 39M 491K –
MEIRAGTX HLDGS PLC COM 48M 11M –
MEREO BIOPHARMA GROUP PLC SPON ADS 5M 1M –
MERUS N V COM 18M 300K –
NANOBIOTIX SPONSORED ADS 3M 555K –
NATERA INC COM 57M 530K –
NAUTILUS BIOTECHNOLOGY INC COM 29M 13M –
NEUROCRINE BIOSCIENCES INC COM 89M 650K –
NOVAVAX INC COM NEW 1M 100K –
NUVALENT INC COM 193M 3M –
OCULAR THERAPEUTIX INC COM 23M 3M –
ORCHESTRA BIOMED HLDGS INC COM 21M 3M –
PEPGEN INC COM 23M 1M –
PRAXIS PRECISION MEDICINES I COM NEW 31M 750K –
PRECISION BIOSCIENCES INC COM NEW 4M 426K –
PROCEPT BIOROBOTICS CORP COM 13M 211K –
PROTAGONIST THERAPEUTICS INC COM 44M 1M –
RAPPORT THERAPEUTICS INC COM 17M 748K –
RECURSION PHARMACEUTICALS IN CL A 6M 769K –
REVANCE THERAPEUTICS INC COM 2M 600K –
REVOLUTION MEDICINES INC *W EXP 12/17/202 26K 250K –
RHYTHM PHARMACEUTICALS INC COM 142M 3M –
ROCKET PHARMACEUTICALS INC COM 27M 1M –
SINGULAR GENOMICS SYSTEMS IN COM NEW 599K 71K –
SKYE BIOSCIENCE INC COM NEW 4M 500K –
SOLENO THERAPEUTICS INC COM 131M 3M –
SOLID BIOSCIENCES INC COM NEW 39M 7M –
SPDR SER TR S&P BIOTECH 2M 23K –
SPRINGWORKS THERAPEUTICS INC COM 62M 2M –
SPYRE THERAPEUTICS INC COM NEW 71M 3M –
STRUCTURE THERAPEUTICS INC SPONSORED ADS 1M 35K –
SURROZEN INC *W EXP 08/01/203 3K 167K –
SYROS PHARMACEUTICALS INC COM NEW 602K 117K –
TACTILE SYS TECHNOLOGY INC COM 748K 63K –
TARSUS PHARMACEUTICALS INC COM 35M 1M –
TEMPUS AI INC CL A 10M 275K –
TRINITY BIOTECH PLC SPONS ARD NEW 4M 2M –
TYRA BIOSCIENCES INC COM 16M 1M –
VAXCYTE INC COM 141M 2M –
VBI VACCINES INC CDA COM NEW 833K 1M –
VERONA PHARMA PLC SPONSORED ADS 35M 2M –
VERRICA PHARMACEUTICALS INC COM 52M 7M –
VERU INC COM 6M 7M –
VIKING THERAPEUTICS INC COM 38M 721K –
VIRIDIAN THERAPEUTICS INC COM 21M 2M –
X4 PHARMACEUTICALS INC COM 2M 4M –
XENON PHARMACEUTICALS INC COM 23M 583K –
ZYMEWORKS INC COM 14M 2M –